Amarin Corp Plc (AMRN)

[jessellivermore]

@twi

The irony of this whole Du situation is the most likely rationale behind the Du decision is a desire to lower the cost of medicine and the cost to individuals...And in fact her decision is not going to have that effect at all...

Since Vascepa actually cuts the cost of health care in the USA (according to ICER)... The fact is use of Vascepa is clearly effected by marketing and the Generics do not market..As a result; the cost of medicine actually goes up..the savings in using a cheaper Tier 1 drug and fewer V scripts (due to less marketing) results in an increase in CVD events due to failing to use Vascepa results in higher medical costs because the cost of treating these events is so much higher than the cost of using Vascepa.."4 gms of prevention is worth more than a pound of procedures.

Maybe Amarin's lawyers can point that out to Du and the learned AC judges..

":>) JL